InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Campbell David Alan. Insider active across 1 company, notably Janux Therapeutics, Inc.. Cumulatively, 10 filings have been logged. Split: 0 buy · 7 sells. Total volume traded: €5.1m. History available since 27 September 2024. The latest transaction was disclosed on 31 July 2026 (Don). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Campbell David Alan is associated with Janux Therapeutics, Inc., where he holds the role of President and CEO. He has 7 filings in total, and across the 7 sampled recent filings between 2024-09-27 and 2025-01-08, they are sales for a total amount of EUR 4959845, with the transaction nature indicated as Sale.